160 related articles for article (PubMed ID: 29740575)
1. Hydroxybenzoic Acid Derivatives as Dual-Target Ligands: Mitochondriotropic Antioxidants and Cholinesterase Inhibitors.
Oliveira C; Cagide F; Teixeira J; Amorim R; Sequeira L; Mesiti F; Silva T; Garrido J; Remião F; Vilar S; Uriarte E; Oliveira PJ; Borges F
Front Chem; 2018; 6():126. PubMed ID: 29740575
[TBL] [Abstract][Full Text] [Related]
2. Fine-tuning the neuroprotective and blood-brain barrier permeability profile of multi-target agents designed to prevent progressive mitochondrial dysfunction.
Benfeito S; Oliveira C; Fernandes C; Cagide F; Teixeira J; Amorim R; Garrido J; Martins C; Sarmento B; Silva R; Remião F; Uriarte E; Oliveira PJ; Borges F
Eur J Med Chem; 2019 Apr; 167():525-545. PubMed ID: 30784884
[TBL] [Abstract][Full Text] [Related]
3. Exploring the Multi-Target Performance of Mitochondriotropic Antioxidants against the Pivotal Alzheimer's Disease Pathophysiological Hallmarks.
Benfeito S; Fernandes C; Vilar S; Remião F; Uriarte E; Borges F
Molecules; 2020 Jan; 25(2):. PubMed ID: 31936622
[TBL] [Abstract][Full Text] [Related]
4. Desrisking the Cytotoxicity of a Mitochondriotropic Antioxidant Based on Caffeic Acid by a PEGylated Strategy.
Fernandes C; Benfeito S; Amorim R; Teixeira J; Oliveira PJ; Remião F; Borges F
Bioconjug Chem; 2018 Aug; 29(8):2723-2733. PubMed ID: 29965741
[TBL] [Abstract][Full Text] [Related]
5. 6-Methyluracil derivatives as acetylcholinesterase inhibitors for treatment of Alzheimer's disease.
Zueva IV; Semenov VE; Mukhamedyarov MA; Lushchekina SV; Kharlamova AD; Petukhova EO; Mikhailov AS; Podyachev SN; Saifina LF; Petrov KA; Minnekhanova OA; Zobov VV; Nikolsky EE; Masson P; Reznik VS
Int J Risk Saf Med; 2015; 27 Suppl 1():S69-71. PubMed ID: 26639718
[TBL] [Abstract][Full Text] [Related]
6. Design, Synthesis and Investigation of New Diphenyl Substituted Pyridazinone Derivatives as Both Cholinesterase and Aβ-Aggregation Inhibitors.
Kilic B; Erdogan M; Gulcan HO; Aksakal F; Oruklu N; Bagriacik EU; Dogruer DS
Med Chem; 2019; 15(1):59-76. PubMed ID: 29792155
[TBL] [Abstract][Full Text] [Related]
7. Benzoic acid-derived nitrones: A new class of potential acetylcholinesterase inhibitors and neuroprotective agents.
Oliveira C; Bagetta D; Cagide F; Teixeira J; Amorim R; Silva T; Garrido J; Remião F; Uriarte E; Oliveira PJ; Alcaro S; Ortuso F; Borges F
Eur J Med Chem; 2019 Jul; 174():116-129. PubMed ID: 31029943
[TBL] [Abstract][Full Text] [Related]
8. Fine-Tuning the Biological Profile of Multitarget Mitochondriotropic Antioxidants for Neurodegenerative Diseases.
Chavarria D; Da Silva O; Benfeito S; Barreiro S; Garrido J; Cagide F; Soares P; Remião F; Brazzolotto X; Nachon F; Oliveira PJ; Dias J; Borges F
Antioxidants (Basel); 2021 Feb; 10(2):. PubMed ID: 33672269
[TBL] [Abstract][Full Text] [Related]
9. Investigating 1,2,3,4,5,6-hexahydroazepino[4,3-b]indole as scaffold of butyrylcholinesterase-selective inhibitors with additional neuroprotective activities for Alzheimer's disease.
Purgatorio R; de Candia M; Catto M; Carrieri A; Pisani L; De Palma A; Toma M; Ivanova OA; Voskressensky LG; Altomare CD
Eur J Med Chem; 2019 Sep; 177():414-424. PubMed ID: 31158754
[TBL] [Abstract][Full Text] [Related]
10. 4,6-Diphenylpyrimidine Derivatives as Dual Inhibitors of Monoamine Oxidase and Acetylcholinesterase for the Treatment of Alzheimer's Disease.
Kumar B; Dwivedi AR; Sarkar B; Gupta SK; Krishnamurthy S; Mantha AK; Parkash J; Kumar V
ACS Chem Neurosci; 2019 Jan; 10(1):252-265. PubMed ID: 30296051
[TBL] [Abstract][Full Text] [Related]
11. Acetamide Derivatives of Chromen-2-ones as Potent Cholinesterase Inhibitors.
Prasad S; Kumar B; Kumar S; Chand K; Kamble SS; Gautam HK; Sharma SK
Arch Pharm (Weinheim); 2017 Aug; 350(8):. PubMed ID: 28699213
[TBL] [Abstract][Full Text] [Related]
12. Synthesis, Characterization and Cholinesterase Inhibition Studies of New Arylidene Aminothiazolylethanone Derivatives.
Channar PA; Shah MS; Saeed A; Khan SU; Larik FA; Shabir G; Iqbal J
Med Chem; 2017; 13(7):648-653. PubMed ID: 28266279
[TBL] [Abstract][Full Text] [Related]
13. Design, synthesis and biological evaluation of benzo[e][1,2,4]triazin-7(1H)-one and [1,2,4]-triazino[5,6,1-jk]carbazol-6-one derivatives as dual inhibitors of beta-amyloid aggregation and acetyl/butyryl cholinesterase.
Catto M; Berezin AA; Lo Re D; Loizou G; Demetriades M; De Stradis A; Campagna F; Koutentis PA; Carotti A
Eur J Med Chem; 2012 Dec; 58():84-97. PubMed ID: 23108363
[TBL] [Abstract][Full Text] [Related]
14. Design, synthesis and evaluation of novel ferulic acid-O-alkylamine derivatives as potential multifunctional agents for the treatment of Alzheimer's disease.
Sang Z; Pan W; Wang K; Ma Q; Yu L; Yang Y; Bai P; Leng C; Xu Q; Li X; Tan Z; Liu W
Eur J Med Chem; 2017 Apr; 130():379-392. PubMed ID: 28279845
[TBL] [Abstract][Full Text] [Related]
15. New multifunctional melatonin-derived benzylpyridinium bromides with potent cholinergic, antioxidant, and neuroprotective properties as innovative drugs for Alzheimer's disease.
Luo XT; Wang CM; Liu Y; Huang ZG
Eur J Med Chem; 2015 Oct; 103():302-11. PubMed ID: 26363866
[TBL] [Abstract][Full Text] [Related]
16. Development of a Mitochondriotropic Antioxidant Based on Caffeic Acid: Proof of Concept on Cellular and Mitochondrial Oxidative Stress Models.
Teixeira J; Cagide F; Benfeito S; Soares P; Garrido J; Baldeiras I; Ribeiro JA; Pereira CM; Silva AF; Andrade PB; Oliveira PJ; Borges F
J Med Chem; 2017 Aug; 60(16):7084-7098. PubMed ID: 28745898
[TBL] [Abstract][Full Text] [Related]
17. Synthesis and Evaluation of Novel Ligustrazine Derivatives as Multi-Targeted Inhibitors for the Treatment of Alzheimer's Disease.
Wu W; Liang X; Xie G; Chen L; Liu W; Luo G; Zhang P; Yu L; Zheng X; Ji H; Zhang C; Yi W
Molecules; 2018 Oct; 23(10):. PubMed ID: 30301153
[TBL] [Abstract][Full Text] [Related]
18. Synthesis, pharmacological assessment, molecular modeling and in silico studies of fused tricyclic coumarin derivatives as a new family of multifunctional anti-Alzheimer agents.
Shaik JB; Palaka BK; Penumala M; Kotapati KV; Devineni SR; Eadlapalli S; Darla MM; Ampasala DR; Vadde R; Amooru GD
Eur J Med Chem; 2016 Jan; 107():219-32. PubMed ID: 26588065
[TBL] [Abstract][Full Text] [Related]
19. Multi-target-directed ligands for Alzheimer's disease: Discovery of chromone-based monoamine oxidase/cholinesterase inhibitors.
Reis J; Cagide F; Valencia ME; Teixeira J; Bagetta D; Pérez C; Uriarte E; Oliveira PJ; Ortuso F; Alcaro S; Rodríguez-Franco MI; Borges F
Eur J Med Chem; 2018 Oct; 158():781-800. PubMed ID: 30245401
[TBL] [Abstract][Full Text] [Related]
20. Design, Synthesis, and Evaluation of Novel Ferulic Acid Derivatives as Multi-Target-Directed Ligands for the Treatment of Alzheimer's Disease.
Sang Z; Wang K; Han X; Cao M; Tan Z; Liu W
ACS Chem Neurosci; 2019 Feb; 10(2):1008-1024. PubMed ID: 30537804
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
